- Enhanced Recovery after Surgery (Eras) and Immunonutrition: An Evidence-based Approach
- Redhill Biopharma Extends Talicia® Unrestricted National and Regional Commercial Coverage to over 40 Million Additional Americans
- Fujifilm Earns Fda “breakthrough Device” Designation for Endosurgical Image Enhancement Technology
- Cognitive Deficit and White Matter Changes in Celiac Disease
- Family History of Colorectal Cancer and Prevalence of Advanced Colorectal Neoplasia in Screening
- Enhanced Recovery after Surgery (Eras) and Immunonutrition: An Evidence-based Approach
- Redhill Biopharma Extends Talicia® Unrestricted National and Regional Commercial Coverage to over 40 Million Additional Americans
- Fujifilm Earns Fda “breakthrough Device” Designation for Endosurgical Image Enhancement Technology
- Cognitive Deficit and White Matter Changes in Celiac Disease
- Family History of Colorectal Cancer and Prevalence of Advanced Colorectal Neoplasia in Screening
- Enhanced Recovery after Surgery (Eras) and Immunonutrition: An Evidence-based Approach
- Redhill Biopharma Extends Talicia® Unrestricted National and Regional Commercial Coverage to over 40 Million Additional Americans
- Fujifilm Earns Fda “breakthrough Device” Designation for Endosurgical Image Enhancement Technology
- Cognitive Deficit and White Matter Changes in Celiac Disease
- Family History of Colorectal Cancer and Prevalence of Advanced Colorectal Neoplasia in Screening
- This event has passed.
Annual Advances in Inflammatory Bowel Diseases (AIBD) Conference AIBD 2020 VISION FOR THE NEXT DECADE
December 9, 2020 - December 12, 2020
Join us for the first-ever virtual Advances in Inflammatory Bowel Diseases (AIBD) conference. Over the last 19 years, AIBD has offered a distinguished level of forward-thinking, clinical education with real-world case studies, and access to leading experts from around the world committed to advancing the care and positive outcomes of patients with IBD. Although the format will be different, the level of high-caliber education delivered will remain unchanged.
The virtual conference will bring together all members in the IBD field—gastroenterologists, nurses, physicians, surgeons, and other healthcare professionals—to take part in a comprehensive program enhanced with progressive treatment strategies and new technology advances that are designed with your patients in mind. For more information, please visit: advancesinibd.com